Catalent, Inc. to Present at the UBS Global Healthcare Virtual Conference

Rhea-AI Summary

Catalent, Inc. (NYSE: CTLT), a global leader in advanced delivery technologies and manufacturing solutions, will present virtually at the UBS Global Healthcare Virtual Conference on May 26, 2021, at 11:00 a.m. ET. The presentation will be available for live streaming and replay on their investor website. With over 85 years of experience, Catalent specializes in bringing drugs, biologics, and consumer health products to market efficiently, generating over $3 billion in revenue in FY 2020, and employing over 14,000 staff across 40 facilities worldwide.

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually present at the UBS Global Healthcare Virtual Conference at 11:00 a.m. ET on May 26, 2021.

A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.

Catalent, Inc. (NYSE: CTLT), an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: https://www.businesswire.com/news/home/20210521005027/en/

FAQ

What is the date and time of Catalent's presentation at the UBS Global Healthcare Virtual Conference?

Catalent's presentation is scheduled for May 26, 2021, at 11:00 a.m. ET.

Where can I watch the live webcast of Catalent's presentation?

The live webcast can be accessed at http://investor.catalent.com.

What is the main focus of Catalent, Inc.?

Catalent specializes in advanced delivery technologies and manufacturing solutions for drugs, biologics, and consumer health products.

How much revenue did Catalent generate in fiscal year 2020?

Catalent generated over $3 billion in revenue in fiscal year 2020.

How many employees does Catalent have?

Catalent employs over 14,000 people, including more than 2,400 scientists and technicians.